Monoclonal Mouse anti‑Human SH3PXD2A / TKS5 Antibody (clone OTI4B8, Carrier‑free, aa299‑395, WB) LS‑C792928
Monoclonal Mouse anti‑Human SH3PXD2A / TKS5 Antibody (clone OTI4B8, Carrier‑free, aa299‑395, WB) LS‑C792928
Antibody:
SH3PXD2A / TKS5 Mouse anti-Human Monoclonal (aa299-395) (Carrier-free) (OTI4B8) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
SH3PXD2A / TKS5 Mouse anti-Human Monoclonal (aa299-395) (Carrier-free) (OTI4B8) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
TKS5 antibody LS-C792928 is an unconjugated mouse monoclonal antibody to human TKS5 (SH3PXD2A) (aa299-395). Validated for WB.
Target
Human SH3PXD2A / TKS5
Synonyms
SH3PXD2A | Adapter protein TKS5 | Adaptor protein TKS5 | FISH | KIAA0418 | SH3 and PX domains 2A | SH3 multiple domains protein 1 | TSK5 | SH3 multiple domains 1 | SH3MD1 | TKS5
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2b
Monoclonal
Conjugations
Unconjugated
Purification
Affinity chromatography
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 299-395 of human SH3PXD2A (NP_055446) produced in E.coli.
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, ELISA
Species:
Human
Applications:
Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, Immunofluorescence, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 1/6/2025